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Background: Clinical practice guidelines (CPGs) become quickly outdated and require a periodic reassessment of
evidence research to maintain their validity. However, there is little research about this topic. Our project will provide
evidence for some of the most pressing questions in this field: 1) what is the average time for recommendations to
become out of date?; 2) what is the comparative performance of two restricted search strategies to evaluate the need to
update recommendations?; and 3) what is the feasibility of a more regular monitoring and updating strategy compared
to usual practice?. In this protocol we will focus on questions one and two.
Methods: The CPG Development Programme of the Spanish Ministry of Health developed 14 CPGs between 2008 and
2009. We will stratify guidelines by topic and by publication year, and include one CPG by strata.
We will develop a strategy to assess the validity of CPG recommendations, which includes a baseline survey of clinical
experts, an update of the original exhaustive literature searches, the identification of key references (reference that
trigger a potential recommendation update), and the assessment of the potential changes in each recommendation.
We will run two alternative search strategies to efficiently identify important new evidence: 1) PLUS search based in
McMaster Premium LiteratUre Service (PLUS) database; and 2) a Restrictive Search (ReSe) based on the least number of
MeSH terms and free text words needed to locate all the references of each original recommendation.
We will perform a survival analysis of recommendations using the Kaplan-Meier method and we will use the log-rank
test to analyse differences between survival curves according to the topic, the purpose, the strength of
recommendations and the turnover. We will retrieve key references from the exhaustive search and evaluate their
presence in the PLUS and ReSe search results.
Discussion: Our project, using a highly structured and transparent methodology, will provide guidance of when
recommendations are likely to be at risk of being out of date. We will also assess two novel restrictive search strategies
which could reduce the workload without compromising rigour when CPGs developers check for the need of updating.
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Clinical practice guidelines (CPGs) are “statements that
include recommendations intended to optimize patient
care that are informed by systematic reviews (SRs) of
evidence and an assessment of the benefits and harms of
alternative care options” [1]. CPGs, just like SRs, become
outdated as new evidence is published and require a
periodic reassessment of research evidence to remain
valid.
Guideline development institutions are concerned about
the growing number of CPGs that are not regularly
updated [2]. However, methodological handbooks include
very little guidance about how to update guidelines other
than to do so periodically [3-5]. In general, despite scant
research [6], guideline programs endorse three years as a
reasonable time period to update their guidelines [7].
Frequently, research in this area focuses on how to
identify new evidence. However updating a GCP is a far
more complex process and includes three main stages:
1) identifying important new evidence; 2) assess if the
new evidence implies the updating of recommendations;
and 3) the actual updating.
The identification of important new evidence that jus-
tifies an update is a challenge. Usually the original ex-
haustive search strategy that has been used to identify
new evidence to update CPGs is used [8,9]. However,
this strategy is very resource intensive, and a barrier to
timely updates. Consequently, some studies have evalu-
ated more restricted searches strategies to assess the
need to update CPGs [10,11]. These strategies are likely
to be sufficient to monitor new evidence and assess the
need to update; however, more information is needed
about the timing and type of search.
Nowadays, other resources could be used to make the
process more efficient [12]. One is the McMaster Premium
Literature Service (PLUS) database, from the McMaster
Health Knowledge Refinery, which contains a searchable
subset of pre-appraised primary studies and SRs from more
than 120 journals and since 2003 [13,14]. The PLUS data-
base includes substantially fewer articles than com-
mon databases, potentially increasing precision, with a
small loss of sensitivity when updating. Recently, PLUS
has been shown to be capable of identifying key articles
that would be needed to update SRs [15]. These results
would suggest that PLUS could prove an efficient method
to update CPGs.
The updating guidelines working group
The Updating Guidelines Working Group goal is to draw
on existing work and knowledge in the area of CPGs up-
dating and to provide guidance for both guideline devel-
opers and users. Our group has run several studies about
CPG updating. We conducted an international survey to
identify current practices in CPG updating across guidelinedevelopment institutions that showed high variability and a
lack of standardization of the updating processes [3]. Add-
itionally we conducted a SR that confirmed that there is
very limited evidence about what is the optimal strategy or
strategies for keeping CPGs up to date [6].
At present we are running several projects to fill this
research gap. Our broader project “Assessing the validity
and update strategies for CPG: analysis of the GPC Na-
tional Program for National Health System in Spain” in-
cludes three studies addressing three pressing questions
in this field: 1) what is the average time for recommenda-
tions to become out of date?; 2) what is the comparative
performance of two restricted search strategies to evalu-
ate the need to update recommendations?; and 3) what is
the feasibility of a more regular monitoring and updating
strategy compared to usual practice?.
Objectives
 Primary objectives:
○Estimate average time for recommendations to
become out of date.
○Evaluate two alternative search strategies to
assess the validity of CPGs recommendations.
 Secondary objectives:
○Design a strategy to assess the validity of CPGs
recommendations.
○Evaluate resources used to perform each strategy.
○Assess the agreement between study participants




Intervention study in a cohort of CPGs recommendations.
Population and eligibility criteria
We will include CPGs developed in the CPG Development
Programme of the Spanish Ministry of Health between 2008
and 2009 that are available in English (Additional file 1). We
will select a sample of four CPGs. We will stratify guidelines
by topic (cancer and palliative care, cardiovascular disease,
mental health and metabolic disease) and then by publica-
tion year (2008 and 2009). We will select one guide for each
topic and two guidelines published in 2008 and two guide-
lines published in 2009. We will choose the guidelines at
random if there is more than one guideline by strata.
Strategies
We will develop a strategy to assess the validity of rec-
ommendations based on the identification (by collating
evidence from clinical experts and by exhaustive litera-
ture searches) and evaluation of new evidence (Table 1).
Table 1 Strategy to assess the validity of recommendations
Stages What How Who
Stage 1 Identification of clinical questions
and recommendations
Review original CPG Guideline methodologist from research group
Stage 2 Baseline survey Recommendation basal survey (http://www.
surveymonkey.com)
Clinical experts
Stage 3 Update exhaustive literature search - Recover original exhaustive literature search - Guideline methodologist from original CPG
- Define the filters that will be used: 1) study
design; 2) publication date
- Information specialist
Stage 4 References database by clinical
questions
Reference management software Information specialist




Stage 6 References matching Reference management software Guideline methodologist from research group
Stage 7 Recommendations database Statistic program Guideline methodologist from research group
Stage 8 Second references screening Stage 8a Reference survey to assess the
updating effect: feasibility test
- Guideline methodologist from original CPG- Guideline
methodologist from research group
- Identification of relevant references
- Identification of key references Stage 8b Sample size calculation Statistician
- Assess the potential changes in
the recommendation
Stage 8c Reference survey to assess the
updating effect (pdf forms)
- Guideline methodologist from original CPG
- Guideline methodologist from research group
- Clinical experts
Stage 9 Final report Final report with study results Guideline methodologist from research group
- Recommendations still valid
- Recommendation needed update
Abbreviations: CPG Clinical practice guideline.
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and a restrictive search strategy (ReSe) for MEDLINE data-
base (Table 3) will be developed.
Strategy to assess the validity of recommendations
 Stage 1: Identification of clinical questions and
recommendations. We will extract the clinical
questions, the recommendations (identified in the
“Summary of recommendations” section) and their
strength (SIGN [16] or GRADE [17] system) forTable 2 PLUS search strategy
Stages What How
Stage 1 Identification contents Review original CPG
Stage 2 PLUS search - Choose existing Me
database related with
- Define the filters th
2) study purpose cat
Stage 3 Reference databases by CPGs Reference managem
Abbreviations: CPG Clinical practice guideline, MeSH Medical Subject Headings, PLUS Premiueach original CPG. Recommendations will be
numbered and classified (prevention, screening,
diagnosis or treatment).
 Stage 2: Baseline survey. Using a similar
approach as Shekelle et al. [10] we will conduct
a survey by e-mail (www.surveymonkey.com)
with clinical experts for each CPG. They will
evaluate whether they consider that
recommendations are up to date and if they
know any new studies that might change the
recommendations (Additional file 2).Who
Guideline methodologist from
research group
SH and SNOMED in PLUS
original CPG contents
PLUS information specialist
at will be used: 1) population;
egories; 3) publication date
ent software PLUS information specialist
m LiteratUre Service, SNOMED Systematized Nomenclature of Medicine.
Table 3 Restrictive search strategy
Stages What How Who
Stage 1 Identification clinical questions Review original CPG Guideline methodologist from research group
Stage 2 Clinical questions eligibility Include clinical questions with ≥ two explicitly
PICO components
Guideline methodologist from research group
Stage 3 ReSe Stage 3a Development ReSe serches Guideline methodologist from research group
Stage 3b Evaluation ReSe serches
Stage 3c Refinement ReSe serches
Stage 3d Define the filters that will be used:
1) study design; 2) publication date
Stage 4 References database by clinical questions Reference management software Guideline methodologist from research group
Abbreviations: CPG Clinical practice guideline, PICO population, intervention, comparator and outcome, ReSe restrictive search.
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of six clinical experts who participated in the CPG
development. Original guideline methodologists will
identify the survey participants: 1) four clinical
experts representing the different areas covered by
the guideline; and 2) two external clinical experts.
 Stage 3: Update literature search. We will recover
the original exhaustive literature searches per
clinical questions.
Information specialists, preferably from the original
guideline, will run the searches in the databases and
apply the corresponding study design filters
(randomised controlled trials [RCTs] or SRs) used in
the original searches. Date filters will be established
from the complete year in which the original search
was completed onwards.
 Step 4: References database by clinical question.
We will cluster the references obtained from the
baseline survey and from the search. We will identify
and eliminate duplicates and build a database by
clinical questions with the references identified.
 Step 5: First reference screening. We will evaluate
whether references are pertinent to the topic of
interest, the study design (RCTs or SRs) and the
publication type (we will include original articles or
abstracts from conferences about original studies)
(Additional file 3).
 Step 6: Reference matching. We will match
pertinent references with one or more related
recommendations.
 Step 7: Recommendations database. We will
analyse the references databases to obtain
recommendations: 1) without references; 2) with low
turnover (≤ median number of references per
recommendation); or 3) with high turnover (> median
number of references per recommendation).
 Step 8: Second reference screening. We will
design a recommendation form to sort out the
pertinent references identified (Additional file 4).
The form will contain: 1) relative to eachrecommendation: clinical question, recommendation,
evidence quality and strength of recommendation;
2) relative to the related references : citation, ±
PubMed Unique Identifier (PMID), abstract and
study design; and 3) relative to the assessed
references: a question to identify relevant
references (references that could be use when
considering the update of a recommendation but
not necessarily trigger a potential update), a
question to identify key references (references that
could potentially trigger a recommendation
update) and a question to assess the potential
changes in the recommendation (in relation with
population, intervention, comparison, outcome,
quality of evidence, direction and/or strength of
the recommendation [18]).
We will send the recommendations forms to clinical
experts and guidelines methodologist by e-mail
(we will schedule three remainders every two weeks).
Each form will be assessed by two clinical experts and
one guideline methodologist. The disagreements will
be resolved by consensus.
 Step 9: Final report. We will prepare a final report
with recommendations that may need updating, in
relation to the new evidence identified. The final
report will be sent the corresponding institutions
that developed these guidelines and the clinicians
who will collaborate in the study.
PLUS search strategy
 Stage 1: Identification topics. We will extract the
topics for each original CPG (identified in “table
of contents”).
 Stage 2: PLUS search. PLUS information specialists
will develop the corresponding search strategies by
matching existing Medical Subject Headings
(MeSH) and Systematized Nomenclature of
Medicine (SNOMED) with the CPGs topics. They
will perform the searches applying PLUS population,
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diagnosis; prognosis; etiology; economics; clinical
predication guide; differential diagnosis) and
publication date filters. No filter will be applied to
select for either original or review articles.
 Stage 3: References database by CPGs. PLUS
information specialists will obtain a database of
references by CPG.
Restrictive search strategy
 Stage 1: Identification of clinical questions. We
will extract the clinical questions for each CPG.
 Stage 2: Clinical questions eligibility. Restrictive
searches will be structured taking into account the
PICO (population, intervention, comparator and
outcome) structure of each clinical question. To
develop each strategy we will include at least two
PICO components from each question and their
corresponding most representative keywords. The
questions that do not explicitly include PICO
components will be excluded.
E.g. an explicit clinical question from the CPG for
Prostate Cancer Treatment is “In patients with
prostate specific antigen (PSA) relapse after radical
prostatectomy, what kind of salvage intervention is
safer and more effective?”. A non explicit clinical
question would be “What is the safest treatment and
most effective option for a patient with prostate
cancer at the locally advanced clinical stage?”. In this
question treatment alternatives are not clearly
defined and make it a very broad question to be
answered by the ReSe strategy [19].
 Stage 3: ReSe. To develop ReSe, based on original
exhaustive search strategy, we will: 1) Select MeSH
terms: If available, for each keyword we will find the
most specific MeSH term (e.g. "Prostate-Specific
Antigen" MeSH term for the population of the
question “In patients with PSA relapse after radical
prostatectomy, what kind of salvage intervention is
safer and more effective?” [19]); 2) Select free text
words [Tw]: for each keyword we will select the
most relevant specifics free text words and search
them in title (e.g. we would select “prostate[ti] AND
specific[ti] AND antigen[ti]” free text words for the
question “In patients with PSA relapse after radical
prostatectomy, what kind of salvage intervention is
safer and more effective?” [19]).
We will evaluate if the ReSe retrieves all original
references considered in the recommendations of
the original CPGs. We will evaluate this by
calculation the proportion of original references
which are retrieved (sensitivity). If a ReSe search
does not find all the original references(sensitivity <100%) we will refine it until it
retrieves them all.
For the refinement, if needed, we will be using one
or both of the following options: 1) use of less
specific MeSH terms; and/or 2) free text words to
search in title or abstract. We will limit each ReSe
by type of design. For each ReSe we will apply the
filter Therapy of the Clinical Study Categories of
Clinical Queries, using both narrow and broad
scope, and we will apply the SR filter developed at
the Health Information Research Unit, McMaster
University [20]. Finally, we will perform the searches
applying publication date filters.
 Step 4: References databases by clinical
questions. For each clinical question we will obtain
three databases, one using the therapy filter plus
narrow scope, one using the therapy filter plus
broad scope, and one using the SR filter.
Outcomes
Primary outcomes
 Average time for recommendations to become out
of date.
 Proportion references that trigger a potential
recommendation update (key references) identified
by the alternative search strategies.
Secondary outcomes
 Resources used by strategy (time and participants).
 Agreement between clinical experts and guideline
methodologists across references screening.
Analysis
Baseline characteristics
We will perform a descriptive analysis of CPGs recommen-
dations included using mean and the standard deviation
(for normal distribution), median and range (for abnormal
distribution) or absolute and relative frequencies (and the
associated 95% CI [confidence interval]), as appropriate.
Strategy performance
We will calculate the proportion and 95% CI of pertin-
ent, relevant and key references identified by the ex-
haustive strategy. We will determine the number of key
references from the exhaustive strategy (gold standard)
retrieved by PLUS and ReSe strategies. We will estimate
the mean time spent on each strategy and the propor-
tion of researchers involved. We will evaluate the
agreement between clinical experts and guideline meth-
odologists about the assessment of key references from
the exhaustive strategy (step 8). We will calculate the
kappa coefficient and the 95% CI, and interpret it
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0.40); moderate (0.41–0.60); substantial (0.61–0.80); and
almost perfect (0.81–1.00) [21].
Survival analysis
We will perform a survival analysis of recommendations.
We will define the event as the identification of a key ref-
erence related to a recommendation. We will consider:
1) recommendation inception date when the original
search of each CPG started; 2) recommendation obsoles-
cence date when first key reference is published for poten-
tial updated recommendations; and 3) last observation
date when the update search of each CPG started for rec-
ommendations is still valid. Finally, we will calculate the
survival time for the potential updated recommendations
(obsolescence date - inception date) and for recommenda-
tions still valid (last observation date - inception date).
The estimated rate of survival of recommendations will
be calculated using the Kaplan-Meier method and we will
use the log-rank test to analyse differences between
survival curves according to the topic (cancer, cardiovascu-
lar disease, mental health or metabolic disease), the pur-
pose (prevention, screening, diagnosis or treatment), the
strength of recommendations and the turnover (number of
references linked per recommendation).
Sample size
In a feasibility test, we sampled 20.9% (52/249) of recom-
mendations from selected CPGs and identified 17 key
references; these warranted an update of eight recom-
mendations (15.4% of recommendations from sample).
Accepting an alpha risk of 0.95 for a precision of ±
0.05 units in a two-sided test for an estimated propor-
tion of 0.154, 112 recommendations randomly selected
from the whole recommendations are required assuming
that such population corresponds to 249 recommenda-
tions. It has been anticipated a replacement rate of 1%.
We will accept p value ≤ 0.05 as significant in all cal-
culations. We will do the analysis with SPSS 18.0 (SPSS
Inc., Chicago, Illinois, United States).
Discussion
In this protocol we are outlining a research project that will
address two important questions about the updating of
guidelines. Our project will provide evidence both: 1) the
assessment of the validity of a cohort of CPGs and; 2) the
evaluation of alternative search strategies to update CPGs
recommendations.
Using a sample of four CPGs developed in the CPG
Development Programme of the Spanish Ministry of
Health we will evaluate two potentially more efficient
search strategies for the updating of guidelines, and com-
pare them to an exhaustive search strategy (our gold stand-
ard). We will include the McMaster Premium LiteratUreService (PLUS), evaluated for the first time in this context,
and an innovative restrictive search strategy. Finally, we
will perform a survival analysis of recommendations pro-
viding additional evidence about this important topic.Our work in the light of previous research
We recently systematically reviewed the research avail-
able about strategies for monitoring and updating CPGs
[6]. We observed that there is limited evidence about
what are the most optimal strategies for this. A restricted
search is likely to be sufficient to monitor new evidence
and assess the need to update; however, more information
is needed about the timing and type of search with only
the exhaustive search strategy having been assessed for the
actual update of CPGs [6]. The development and evalu-
ation of more efficient strategies is hence needed to im-
prove the timeliness and reduce the burden of maintaining
the validity of CPGs.
Only one previous study by Shekelle et al. [10] analysed
the survival time of CPGs and suggested that these should
be reassessed every three years. We built on the method-
ology proposed in this study addressing some of its short-
comings. First we will use an exhaustive search strategy, as
opposed to the restrictive used by Shekelle et al. [10], that
will likely provide a more reliable estimate. We will analyse
our results in terms of recommendations out of date, in-
stead of CPGs out of date. Finally, we will also publish a
more detailed and explicit approach that will allow devel-
opers to be able to implement it in their institutions.
One previous study evaluated the McMaster Premium
LiteratUre Service (PLUS) for the updating of SRs with
promising results. We therefore decided to include this
free of access service as a potential resource that could
prove to be highly efficient.
Given all of the above, our research project is timely and
fits well with the needs from the guideline community.Strengths and limitations
Our study has several strengths. We will use a rigorous
and transparent methodology, both to assess the validity
of recommendations as well as the performance of the
search strategies. We are building on previous research in
this area improving its deficiencies [10] and implementing
innovative solutions (e.g. standardized reporting) [6]. We
will compare three search strategies, head to head, some-
thing that only one study, by Gartlehner 2004 et al. [11],
has done so far. That study found that the restrictive
search (review approach) identified fewer studies but in-
cluded all-important references rated by their task force.
Nevertheless they only evaluated their final strategy in two
topics, the results being inconsistent. Finally our group has
important expertise in guideline updating [3,6,22] and
guideline methodology in general [23,24].
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searches by type of study including only SRs and RCTs,
however, we think it is unlikely that we will miss import-
ant studies that will compromise the generalisability of
our findings. Our study will not include the actual up-
dating of the guidelines identified to be out of date and,
hence, we will not evaluate whether our strategies are
optimal for the final updating. Nevertheless, we believe
that our outcome is a reliable surrogate of actual
updating.Implications of this study
We expect that our work will produce one or more effi-
cient strategies to assess the validity of recommenda-
tions, and provide detailed guidance to replicate the
process. Furthermore, our results will inform guideline
developers about the expected validity of their recom-
mendations in a representative sample of guidelines from
a typical cohort of a National Guideline program. If the
evaluated search strategies perform optimally, our work
could be highly influential for evidence surveillance. Our
results could therefore have important implications for a
more efficient use of resources in the CPG arena.Additional files
Additional file 1: Clinical practice guidelines developed within the
framework of the CPG Development Programme of the Spanish
Ministry of Health between 2008 and 2009.
Additional file 2: Recommendation baseline survey to clinical
experts. Example on clinical practice guideline for secondary prevention
of stroke (2009) [25].
Additional file 3: Reference screening by pertinence.
Additional file 4: Reference survey to assess the updating effect.
Example on clinical practice guideline for secondary prevention of
stroke (2009) [25].Abbreviations
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